sacituzumab govitecan Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Female only (1)
Any (1)

Phase 2 (2)

Interventional (2)

Alessandro Santin (1)
Dana-Farber Cancer Institute (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadprogrammed cell death 1 ligand 1

I am/have/hadmeasurable disease

I am/have/hadalopecia

I am/have/hadHER2

I am/have/hadneutrophil count

I am/have/hadtriple-negative breast cancer

I am/have/hadwhole brain radiotherapy

I am/have/hadstage iv breast cancer

I am/have/hadbrain metastasis

I am/have/hadrecurrent endometrial cancer

I am/have/hadliver metastasis

I am/have/hadendometrial carcinoma

I am/have/hadcarcinoma

I am/have/hadx rays

I am/have/hadanticoagulant therapy

I am/have/hadct scan

I am/have/hadbreast cancer

I am/have/hadrecurrent disease

I am/have/hadprogesterone

I am/have/hadmetastasis

added new label for I am/have/had

more

I am looking for

I am looking forprednisone

I am looking forplatinum-based chemotherapy

I am looking forestrogen

I am looking forkeytruda

I am looking forhormone therapy

I am looking forendocrine therapy

I am looking foradjuvant

I am looking forimmunostimulant

I am looking foranticoagulants

I am looking forpembrolizumab

I am looking forcorticosteroids

I am looking forbisphosphonate

I am looking foririnotecan

I am looking forsacituzumab govitecan

I am looking formk-3475

I am looking forcopper

I am looking forimmunomodulators

I am looking forprogesterone

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
For Females
Family Medicine
Recruiting

A Study of Sacituzumab Govitecan (IMMU-132) in Endometrial Carcinoma

This is a non-randomized Phase 2 study of sacituzumab govitecan (IMMU-132) in subjects with persistent or recurrent endometrial carcinoma.

measurable disease

prednisone

non-target

plain x-ray

platinum-based chemotherapy

0 views
19 Feb, 2024

Phase 2
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Cardiovascular Diseases
Recruiting

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

The names of the study interventions involved in this study are: Sacituzumab govitecan (IMMU-132) Pembrolizumab (Keytruda; MK-3475)

programmed cell death 1 ligand 1

measurable disease

alopecia

triple-negative breast cancer

HER2

8 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.